tiprankstipranks
Entheon Biomedical (TSE:ENBI)
:ENBI
Canadian Market
ENBI
Entheon Biomedical
RESEARCH TOOLSreports

Entheon Biomedical (ENBI) Financial Statements

16 Followers

Entheon Biomedical Financial Overview

Entheon Biomedical's market cap is currently C$1.39M. The company's EPS TTM is C$-0.005; its P/E ratio is -3.72; Entheon Biomedical is scheduled to report earnings on March 27, 2026, and the estimated EPS forecast is C$―. See an overview of income statement, balance sheet, and cash flow financials.
Nov 25Feb 25Feb 24Feb 23Feb 22
Income Statement
Total RevenueC$ 0.00C$ 0.00C$ 250.32KC$ 189.68KC$ 21.67K
Gross ProfitC$ 0.00C$ 0.00C$ 250.32KC$ 189.68KC$ 9.13K
Operating IncomeC$ -334.22KC$ -333.00KC$ -313.00KC$ -3.60MC$ -8.21M
EBITDAC$ -334.22KC$ -318.00KC$ 13.99KC$ -3.60MC$ -8.21M
Net IncomeC$ -324.01KC$ -318.00KC$ -300.00KC$ -8.52MC$ -8.89M
Balance Sheet
Cash & Short-Term InvestmentsC$ 321.83KC$ 136.49KC$ 344.63KC$ 680.17KC$ 2.05M
Total AssetsC$ 353.78KC$ 185.14KC$ 401.08KC$ 769.22KC$ 9.98M
Total DebtC$ 0.00C$ 0.00C$ 0.00C$ 0.00C$ 0.00
Net DebtC$ -321.83KC$ -136.49KC$ -344.63KC$ -680.17KC$ -2.05M
Total LiabilitiesC$ 29.75KC$ 39.81KC$ 85.33KC$ 154.65KC$ 927.71K
Stockholders' EquityC$ 324.03KC$ 145.33KC$ 315.75KC$ 614.57KC$ 9.05M
Cash Flow
Free Cash FlowC$ -314.66KC$ -355.64KC$ -359.93KC$ -1.95MC$ -5.71M
Operating Cash FlowC$ -314.66KC$ -355.64KC$ -359.93KC$ -1.95MC$ -5.62M
Investing Cash FlowC$ 0.00C$ 0.00C$ 24.40KC$ 585.64KC$ -98.87K
Financing Cash FlowC$ 500.00KC$ 147.50KC$ 0.00C$ 0.00C$ 4.98M
Currency in CAD

Entheon Biomedical Earnings and Revenue History

Income Statement >

Entheon Biomedical Debt to Assets

Balance Sheet >

Entheon Biomedical Cash Flow

Cash Flow >

Entheon Biomedical Forecast EPS vs Actual EPS

Earnings >